当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析 - 现金流量表

甘李药业

(603087)

  

流通市值:386.20亿  总市值:410.97亿
流通股本:5.61亿   总股本:5.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,166,514,893.111,090,250,158.473,782,135,444.222,799,253,112.31
  收到的税费返还29,327,502.342,386,431.9193,509,005.3485,506,119.06
  收到其他与经营活动有关的现金37,580,826.767,832,632.42109,281,003.2775,818,636.58
  经营活动现金流入小计2,233,423,222.211,100,469,222.83,984,925,452.832,960,577,867.95
  购买商品、接受劳务支付的现金469,234,555.86232,102,273.63931,735,126.4725,969,731.03
  支付给职工以及为职工支付的现金558,938,706.3249,657,172.461,056,185,817.04764,768,091.94
  支付的各项税费251,296,547.4153,438,987.04249,605,277.71237,385,212.17
  支付其他与经营活动有关的现金521,631,234.18293,596,390.05963,123,964.32750,494,376.24
  经营活动现金流出小计1,801,101,043.74928,794,823.183,200,650,185.472,478,617,411.38
  经营活动产生的现金流量净额432,322,178.47171,674,399.62784,275,267.36481,960,456.57
二、投资活动产生的现金流量:
  收回投资收到的现金4,945,880,8002,141,017,904.816,572,046,8704,862,623,970
  取得投资收益收到的现金67,417,390.1331,481,665.1592,611,984.3879,501,731.75
  处置固定资产、无形资产和其他长期资产收回的现金净额--753,211.8118,056
  处置子公司及其他营业单位收到的现金净额--309,616,697.13-
  收到的其他与投资活动有关的现金-2,936,859.65--
  投资活动现金流入小计5,013,298,190.132,175,436,429.616,975,028,763.324,942,143,757.75
  购建固定资产、无形资产和其他长期资产支付的现金527,653,786.51309,117,926.09926,089,327.81627,863,920.32
  投资支付的现金4,520,872,2002,120,968,4006,012,960,144.933,982,756,561.06
  投资活动现金流出小计5,048,525,986.512,430,086,326.096,939,049,472.744,610,620,481.38
  投资活动产生的现金流量净额-35,227,796.38-254,649,896.4835,979,290.58331,523,276.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金4,725,138.832,000,000--
  收到其他与筹资活动有关的现金148,767,023.36---
  筹资活动现金流入平衡项目00--
  筹资活动现金流入小计153,492,162.192,000,000--
  分配股利、利润或偿付利息支付的现金597,304,969-597,525,269597,197,899
  支付其他与筹资活动有关的现金887,873.08241,788.6140,249,076.74140,071,249.6
  筹资活动现金流出小计598,192,842.08241,788.6737,774,345.74737,269,148.6
  筹资活动产生的现金流量净额-444,700,679.891,758,211.4-737,774,345.74-737,269,148.6
四、汇率变动对现金及现金等价物的影响-2,804,177.03-2,074,601.281,172,093.722,686,658.89
五、现金及现金等价物净增加额-50,410,474.83-83,291,886.7483,652,305.9278,901,243.23
  加:期初现金及现金等价物余额343,707,442.68343,530,556.97260,055,136.76260,055,136.76
  期末现金及现金等价物余额293,296,967.85260,238,670.23343,707,442.68338,956,379.99
补充资料:
  净利润609,335,274.74-1,143,583,603.28-
  资产减值准备7,312,511.56-36,125,457.82-
  固定资产和投资性房地产折旧164,106,590.67-287,261,585.84-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧164,106,590.67-287,261,585.84-
  无形资产摊销20,355,509.13-14,809,333.23-
  长期待摊费用摊销10,379.53-1,768,469.35-
  处置固定资产、无形资产和其他长期资产的损失54,154.92--3,712,360.69-
  固定资产报废损失180,633.63-1,060,424.42-
  公允价值变动损失-13,594,291.86--73,818,236.87-
  财务费用-40,335,314.48--81,555,401.19-
  投资损失-29,123,030.54--290,775,382.32-
  递延所得税37,403,010.43--53,308,217.73-
  其中:递延所得税资产减少16,791,225.9--60,497,518.65-
    递延所得税负债增加20,611,784.53-7,189,300.92-
  存货的减少-54,952,933.46--28,868,123.06-
  经营性应收项目的减少-224,263,927.83--364,475,894.21-
  经营性应付项目的增加-57,679,091.16-106,221,072.41-
  其他15,480,010.11-73,589,075.8-
  不涉及现金收支的投资和筹资活动金额其他项目23,496,063.44-10,818,466.54-
  现金的期末余额293,296,967.85-343,707,442.68-
  减:现金的期初余额343,707,442.68-260,055,136.76-
  现金及现金等价物的净增加额-50,410,474.83-83,652,305.92-
公告日期2026-08-262026-04-232026-04-232025-10-31
审计意见(境内)标准无保留意见
TOP↑